Skip to main content
Clinical Trials/NCT03972397
NCT03972397
Completed
Phase 4

Intercostal Nerve Cryoablation for Postoperative Pain Management

The University of Texas Health Science Center, Houston1 site in 1 country20 target enrollmentJuly 15, 2019

Overview

Phase
Phase 4
Intervention
Intercostal Nerve Cryoablation
Conditions
Pain, Postoperative
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
20
Locations
1
Primary Endpoint
5-point Satisfaction Scale
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the study is to assess the efficacy of intercostal nerve cryoablation on the magnitude and duration of postoperative pain control both in patients undergoing thoracoabdominal incisions for the descending or thoracoabdominal aortic aneurysm repair.

Registry
clinicaltrials.gov
Start Date
July 15, 2019
End Date
September 22, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Anthony L Estrera

Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Descending/thoracoabdominal incision is planned
  • There is reasonable expectation that the patient will be extubated within 48 hours after surgery

Exclusion Criteria

  • The patient has a known allergy to morphine or any opioid
  • The patient has a known chronic pain disorder or takes daily opioid medication \> 1 month prior to surgery
  • The surgeon/anesthesiologist concludes that the period for intubation will be likely be for more than 48 hours after surgery There is anticipated difficulty communicating pain status due to language or other barriers at the investigator discretion.

Arms & Interventions

Intercostal Nerve Cryoablation plus SOC Pain Control

Standard of Care (SOC)

Intervention: Intercostal Nerve Cryoablation

Intercostal Nerve Cryoablation plus SOC Pain Control

Standard of Care (SOC)

Intervention: Bupivacaine liposomal injectable suspension

Intercostal Nerve Cryoablation plus SOC Pain Control

Standard of Care (SOC)

Intervention: Patient-controlled analgesia (PCA)

Standard of Care (SOC) Pain Control

Intervention: Bupivacaine liposomal injectable suspension

Standard of Care (SOC) Pain Control

Intervention: Patient-controlled analgesia (PCA)

Outcomes

Primary Outcomes

5-point Satisfaction Scale

Time Frame: post-operative day 180

The 5-point satisfaction scale assesses post-surgical analgesia satisfaction. The total score ranges from 1 to 5, with 1 being "very dissatisfied" and 5 being "very satisfied".

Score on Numeric Pain Scale (NPS)

Time Frame: post-operative day 5

The NPS measures the intensity of pain. The total score ranges from 0 to 10, with 0 being no pain and 10 the highest pain.

Brief Pain Inventory (BPI) - Severity Score

Time Frame: post-operative day 180

The Brief Pain Inventory is a medical questionnaire used to measure pain, developed by the Pain Research Group of the WHO Collaborating Centre for Symptom Evaluation in Cancer Care. The total severity score ranges from 0 to 10, with 0 indicating no pain and 10 indicating pain as bad as you can imagine.

Brief Pain Inventory (BPI) - Pain Interference Score

Time Frame: post-operative day 180

The Brief Pain Inventory is a medical questionnaire used to measure pain, developed by the Pain Research Group of the WHO Collaborating Centre for Symptom Evaluation in Cancer Care. The pain interference score indicates how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others, and sleep. The total pain interference score ranges from 0 to 10, with 0 indicating no interference and 10 indicating complete interference.

Secondary Outcomes

  • Total Amount in mg of Opioid Medication Consumed(third to fifth post-operative days after surgery)
  • Number of Participants Who Require of Opioids at the Time of Discharge(at the time of discharge (about a week after surgery))
  • Number of Participants Who Utilize Patient-controlled Analgesia (PCA)(from the time immediately after surgery to post-operative day 3)
  • Amount of Patient-controlled Analgesia (PCA) Used(from the time immediately after surgery to post-operative day 3)
  • Number of Participants Who Attain Physical Therapy Goal That Justifies Discharge From Inpatient Physical Therapy Within 72 Hours(72 hours after surgery)
  • Length of Hospital Stay(at the time of discharge (about a week after surgery))
  • Hospital Cost for Patient Care During Hospitalization(at the time of discharge (about a week after surgery))

Study Sites (1)

Loading locations...

Similar Trials